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Motivation:  Single-centre  studies  in medical  domain  are  often  characterised  by  limited  samples  due  to the
complexity  and high  costs  of  patient  data  collection.  Machine  learning  methods  for regression  modelling
of small  datasets  (less  than  10 observations  per  predictor  variable)  remain  scarce.  Our work  bridges  this
gap  by developing  a novel  framework  for application  of artiﬁcial  neural  networks  (NNs)  for  regression
tasks  involving  small  medical  datasets.
Methods:  In order  to address  the  sporadic  ﬂuctuations  and validation  issues  that  appear  in regression  NNs
trained  on  small  datasets,  the  method  of  multiple  runs  and surrogate  data  analysis  were  proposed  in this
work. The  approach  was  compared  to the  state-of-the-art  ensemble  NNs;  the  effect  of  dataset  size on  NN
performance  was  also  investigated.
Results:  The  proposed  framework  was applied  for the  prediction  of compressive  strength  (CS) of  femoral
trabecular  bone  in patients  suffering  from  severe  osteoarthritis.  The  NN  model  was  able  to  estimate
the  CS  of  osteoarthritic  trabecular  bone  from  its  structural  and  biological  properties  with  a standard
error  of 0.85  MPa.  When  evaluated  on  independent  test  samples,  the NN achieved  accuracy  of 98.3%,
outperforming  an ensemble  NN  model  by  11%.  We  reproduce  this  result  on  CS data  of  another  porous
solid  (concrete)  and  demonstrate  that  the  proposed  framework  allows  for an  NN  modelled  with as  few
as  56  samples  to  generalise  on 300  independent  test  samples  with  86.5%  accuracy,  which  is  comparable
to  the performance  of an NN developed  with  18  times  larger  dataset  (1030  samples).
Conclusion:  The  signiﬁcance  of  this  work  is  two-fold:  the  practical  application  allows  for  non-destructive
prediction  of bone  fracture  risk, while  the  novel  methodology  extends  beyond  the task  considered  in
this  study  and  provides  a general  framework  for application  of  regression  NNs  to  medical  problems
characterised  by  limited  dataset  sizes.
© 2017  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND. Introduction
IN recent decades, a surge of interest in Machine learning
ithin the medical research community has resulted in an array
f successful data-driven applications ranging from medical image
rocessing and the diagnosis of speciﬁc diseases, to the broader
asks of decision support and outcome prediction [1–3]. The focus
f this work is on predictive modelling for applications charac-
erised by small datasets and real-numbered continuous outputs.
uch tasks are normally approached by using conventional multi-
le linear regression models. These are based on the assumptions
f statistical independence of the input variables, linearity between
ependent and independent variables, normality of the residuals,
∗ Corresponding author.
E-mail address: n.khovanova@warwick.ac.uk (N.A. Khovanova).
ttp://dx.doi.org/10.1016/j.artmed.2016.12.003
933-3657/© 2017 The Authors. Published by Elsevier B.V. This is an open access article 
/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
and the absence of endogenous variables [4]. However, in many
applications, particularly those involving complex physiological
parameters, those assumptions are often violated [5]. This necessi-
tates more sophisticated regression models based, for instance, on
Machine learning. One such approach – predictive modelling using
feedforward backpropagation artiﬁcial neural networks (NNs) –
is considered in this work. NN is a distributed parallel processor
which resembles a biological brain in the sense that it learns by
responding to the environment and stores the acquired knowledge
in interneuron synapses [6]. One striking aspect of NNs is that they
are universal approximators. It has been proven that a standard
multilayer feedforward NN is capable of approximating any mea-
surable function and that there are no theoretical constraints for
the success of these networks [7]. Even when conventional mul-
tiple regression models fail to quantify a nonlinear relationship
between causal factors and biological responses, NNs retain their
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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apacity to ﬁnd associations within high-dimensional, nonlinear
nd multimodal medical data [8,9].
Despite their superior performance, accuracy and versatility,
Ns are generally viewed in the context of the necessity for abun-
ant training data. This, however, is rarely feasible in medical
esearch, where the size of datasets is constrained by the complex-
ty and high cost of large-scale experiments. Applications of NNs for
egression analysis and outcome prediction based on small datasets
emain scarce and thus require further exploration [2,9,10]. For the
urposes of this study, we  deﬁne small data as a dataset with less
han ten observations (samples) per predictor variable.
NNs trained with small datasets often exhibit unstable
ehaviour in performance, i.e. sporadic ﬂuctuations due to the
ensitivity of NNs to initial parameter values and training order
11–13]. NN initialisation and backpropagation training algorithms
ommonly contain deliberate degrees of randomness in order to
mprove convergence to the global minimum of the associated cost
unction [6,9,12,14]. In addition, the order with which the train-
ng data is fed to the NN can affect the level of convergence and
roduce erratic outcomes [12,13]. Such inter-NN volatility limits
oth the reproducibility of the results and the objective comparison
etween different NN designs for future optimisation and valida-
ion. Previous attempts [15] to resolve the stability problems in NNs
emonstrated the success of k-fold cross-validation and ensemble
ethods for a medical classiﬁcation problem; the dataset com-
rised 53 features and 1355 observations, which corresponds to 25
bservations per predictor variable. To the best of our knowledge,
ffective strategies for regression tasks on small biomedical datasets
ave not been considered, thus necessitating the establishment of
 framework for application of NNs to medical data analysis.
One important biomedical application of NNs in hard tissue
ngineering was considered in our previous work [11,16], where a
N was applied for correlation analysis of 35 trabecular bone sam-
les from male and female specimens of various ages suffering from
evere osteoarthritis (OA) [17]. OA is common degenerative joint
isease associated with damaged cartilage [18]. Unlike in osteo-
orosis, where decreasing bone mineral density (BMD) decreases
one compressive strength (CS) and increases bone fracture risk,
he BMD  in OA was seen to increase [19,20]. There is further indi-
ation that higher BMD  does not protect against bone fracture risk
n OA [19,21]. The mathematical relationship between BMD  and CS
bserved in healthy patients does not hold for patients with OA,
ecessitating development of a CS model for OA.
In the current work, we consider the application of NNs to
steoarthritic hip fracture prediction for non-invasive estimation
f bone CS from structural and physiological parameters. For this
articular application there are two commonly used computational
echniques: quantitative computed tomography-based ﬁnite ele-
ent analysis [22,23] and the indirect estimation of local properties
f bone tissue through densitometry [24,25]. Yet, subject-speciﬁc
odels for hip fracture prediction from structural parameters of
rabecular bone in patients affected by degenerative bone diseases
ave not been developed. An accurate patient data driven model for
S estimation based on NNs could offer a hip fracture risk stratiﬁ-
ation tool and provide valuable clinical insights for the diagnosis,
revention and potential treatment of OA [26,27].
The aim of this research is to develop subject-speciﬁc mod-
ls for hip fracture prediction in OA and a general framework for
he application of regression NNs to small datasets. In this work
e introduce the method of multiple runs to address the inter-NN
olatility problem caused by small data conditions. By generating
 large set (1000+) of NNs, this method allows for consistent com-
arison between different NN designs. We  also propose surrogate
ata test in order to account for the random effects due to small
atasets. The use of surrogate data was inspired by their success-lligence in Medicine 75 (2017) 51–63
ful application in nonlinear physics, neural coding, and time series
analysis [28–30].
The utility of the proposed framework was explored by consid-
ering a larger dataset. Due to the unavailability of a large number
of bone samples, a different CS dataset, that of 1030 samples of
concrete, was used [31,32]. We  designed and trained regression
NNs for several smaller subsets of the data and demonstrated that
small-dataset (56 samples) NNs developed using our framework
can achieve a performance comparable to that of the NNs developed
on the entire dataset (1030 samples).
The structure of this article is as follows. Section 2 describes the
data used for analysis, NN model design, and introduces the new
framework. In Section 3, the role of data size on NN performance
and generalisation ability is explored to demonstrate the utility of
the proposed framework. In Section 4 we  apply our framework for
prediction of osteoarthritic trabecular bone CS and demonstrate the
superiority of the approach over established ensemble NN methods
in the context of small data. Section 5 discusses both the method-
ological signiﬁcance of the proposed framework and the medical
application of the NN model for prediction of hip fracture risk. Addi-
tional information on NN outcomes and datasets is provided in the
Appendices.
2. Methodology
2.1. Porous solids: data
2.1.1. Compressive strength of trabecular bone
Included in this study are 35 patients who suffered from severe
OA and underwent total hip arthroplasty (Table A1, Appendix A).
The original dataset [17] obtained from trabecular tissue samples
taken from the femoral head of the patients contained ﬁve pre-
dictor features (a 5-D input vector for the NN): patients’ age and
gender, tissue porosity (BV/TV), structure model index (SMI), tra-
becular thickness factor (tb.th), and one output variable, the CS (in
MPa). The dataset was  divided at random into training (60%), val-
idation (20%) and testing (20%) subsets, i.e. 22, 6 and 7 samples,
respectively.
2.1.2. Compressive strength of concrete
The dataset [31] of 1030 samples was obtained from a publically
available repository [32] and contained the following variables:
compressive strength (CS) of concrete samples (in MPa), the
amounts of 7 components in the concrete mixture (in kg/m3):
cement, blast furnace slag, ﬂy ash, water, superplasticizer, coarse
and ﬁne aggregates, and the duration of concrete aging (in days).
The CS of concrete is a highly nonlinear function of its compo-
nents and the duration of aging, yet an appropriately trained NN
can effectively capture this complex relationship between the CS
and the other 8 variables. A successful application of NNs to CS pre-
diction based on 700 concrete samples has been demonstrated in
an original study by Yeh [31]. For the purposes of our NN modelling,
the samples were divided at random into training (60%), validation
(10%) and testing (30%). Thus, out of 1030 available samples, 630
were used for NN training, 100 for validation and 300 were reserved
for testing.
2.2. NN design for CS prediction in porous solids
Considering the size and nature of the available data, a feedfor-
ward backpropagation NN with one hidden layer, p input features
and one output was chosen as the base for the CS model (Fig. 1).
The k neurons in the hidden layer is characterised by a hyperbolic
tangent sigmoid transfer function [33], while the output neuron
relates the CS output to the input by using a simple linear transfer
function (Fig. 1).
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-dimensional input, k-neuron hidden layer and 1 output variable.
The p-by-k input weights matrix IW ,  k-by-1 layer weights col-
mn  vector lw′, and the corresponding biases b(1) and b(2) for each
ayer were initialised according to the Nguyen-Widrow method
34] in order to distribute the active region of each neuron in the
ayer evenly across the layer’s input space.
The NNs were trained using the Leverberg-Marquardt back-
ropagation algorithm [35–37]. The cost function was  deﬁned by
he mean squared error (MSE) between the output and actual CS
alues. Early stopping on an independent validation cohort was
mplemented in order to avoid NN overtraining and increase gen-
ralisation [38]. The validation subset was sampled at random from
he model dataset for each NN, ensuring a diversity among the sam-
les. The resulting NN model mapped the output y (in MPa) to the
nput vector x¯  is:
 = tanh
[
x¯ · IW + b(1)
]
· lw′ + b(2) (1)
The ﬁnal values of the weights and bias parameters in (1) for the
rained bone data NN are provided in Table A3 in Appendix B.
Note, parameter estimation for the optimal network structure,
ize, training duration, training function, neural transfer function
nd cost function was conducted at the preliminary stage following
n established textbook practice [6,9]. Assessment and compari-
on of various NN designs were carried out using the multiple runs
echnique.
.3. Method of multiple runs
In order to address the small dataset problem we introduce the
ethod of multiple runs in which a large number of NNs of the same
esign are trained simultaneously. In other words, the performance
f a given NN design is assessed not on a single NN instance, but
epeatedly on a set (multiple run) of a few thousands NNs. Iden-
ical in terms of their topology and neuron functions, NNs within
ach such run differ due to the 3 sources of randomness deliber-
tely embedded in the initialisation and training routines: (a) the
nitial values of the layer weights and biases, (b) the split between
he training and validation datasets (test samples were ﬁxed), and
c) the order with which the training and validation samples are fed
nto the NN. In every run, several thousand NNs with various initial
onditions are generated and trained in parallel, producing a range
f successful and unsuccessful NNs evaluated according to criteria
et in Section 2.7. Subsequently, their performance indicators are
eported as collective statistics across the whole run, thus allow-
ng consistent comparisons of performance among runs despite the
imited size of the dataset. This helps to quantify the varying effects
f design parameters, such as the NN’s size and the training dura-
ion during the iterative parameter estimation process. Finally, the
ighest performing instance of the optimal NN design is selected
s the working model. This strategy principally differs from NN
nsemble methods (as discussed below in Section 2.6) in the sense
hat only the output of a single best performing NN is ultimately
elected as the working (optimal) model.lligence in Medicine 75 (2017) 51–63 53
In summary, the following terminology applies throughout the
paper:
• design parameters are NN size, neuron functions, training func-
tions, etc.
• individual NN parameters are weights and biases
• optimal NN design is based on estimation of appropriate NN size,
topology, training functions, etc.
• working (optimal) model is the highest performing instance
selected from a run of the optimal NN design.
The choice of the number of NNs per run is inﬂuenced by the
balance between the required precision of the statistical mea-
sures and computational efﬁciency, as larger runs require more
memory and time to simulate. It was found that for the bone CS
application considered in this study, 2000 NNs maintained most
performance statistics, such as mean regression between NN tar-
gets and predictions, consistent to 3 decimal places, which was
deemed sufﬁcient. For inter-run consistency each 2000 NN run was
repeated 10 times, yielding 20,000 NNs in total. The average sim-
ulation time for instantiating and training a run of 2000 NNs on
a modern PC (Intel
®
CoreTM i7-3770 CPU @3.40 GHz, 32 GB RAM)
was 280 s.
2.4. Surrogate data test
Where a sufﬁcient number of samples is available, the efﬁciency
of learning by NN of the interrelationships in the data is expected to
correlate with its test performance. With small datasets, however,
the efﬁciency of learning is decreased and even poorly-designed
NNs can achieve a good performance on test samples at random.
In order to avoid such situation and to evaluate NN performance in
the presence of random effects, a surrogate data test is proposed in
this study. Surrogate data mimics the statistical properties of the
original dataset independently for each component of the input
vector. While resembling the statistical properties of the original
data, the surrogates do not retain the intricate interrelationships
between the various components of the real dataset. Hence, the
NN trained and tested on surrogates is expected to perform poorly.
Numerous surrogate data NNs are generated using method of
multiple runs described in Section 2.3. The highest performing sur-
rogate NN instance deﬁnes the lowest performance threshold for
real data models. To pass the surrogate data test, real data NNs must
outperform this threshold.
The surrogate samples can be generated using a variety of
methods [29,39,40]. In this study two approaches were used. For
trabecular bone data, all continuous input variables were normally
distributed according to the Kolmogorov-Smirnov statistical test
[4]. Thus surrogates were generated from random numbers to
match the truncated normal distributions, e.g. mean and standard
deviation estimated from the original data, as well as the range and
size of the original tissue samples (Table A2, Appendix A). For the
concrete data, where vector distributions were not normal, random
permutations [4] of the original vectors were applied.
2.5. Summary of the proposed framework
Combined, the method of multiple runs and surrogate data test
comprise a framework for application of regression NNs to small
datasets, as summarised in Fig. 2. Multiple runs enable (i) consis-
tent comparison of various NN designs during design parameter
estimation, (ii) comparison between surrogate data and real data
NNs during surrogate data test, and (iii) selection of the working
model among the models of optimal design.
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mig. 2. Proposed framework for application of regression neural networks to small
atasets.
.6. Assessing NN generalisation
In the context of ML,  generalising performance is a measure of
ow well a model predicts an outcome based on independent test
ata with which the NN was not previously presented. In recent
ecades considerable efforts in ML  have been dedicated to improv-
ng the generalisation of NNs [41,42]. A data-driven predictive
odel has little practical value if it is not able to form accurate
redictions on new data. Yet in small datasets, where such test
ata are scarce, the simple task of assessing generalisation becomes
mpractical. Indeed, reserving 20% of the bone data for independent
esting leaves us with only 7 samples. The question of whether the
N model would generalise on a larger set of new samples can-
ot be illustrated with such limited test data. This poses a major
bstacle for small medical datasets in general, thus the effect of
ataset size on NN performance must be considered. We  investi-
ate the effect of the model dataset size on the generalisation ability
f the NN models developed with our framework on a large dataset
f concrete CS samples described in Section 2.1. The ﬁndings are
resented in Section 3.4.
.7. Performance criteria
In order to assess the performance of an individual NN, including
he best performing, the linear regression coefﬁcients R between
he actual output (target) and predicted output were calculated.
n particular, regression coefﬁcients were calculated for the entire
ataset (Rall), and separately for training (Rtrain), validation (Rval),
nd testing (Rtest). R can take values between 0 and 1, where 1
orresponds to the highest model predictive performance (100%
ccuracy) with equal target and prediction values. R greater than 0.6
eﬁnes statistically signiﬁcant performance, i.e. Rall ≥ 0.6, Rtrain ≥
.6, Rval ≥ 0.6, and Rtest ≥ 0.6〈REFNUMLINK〉 [11].
The root mean squared error (RMSE) across the entire dataset
as also assessed. RMSE presents the same information regarding
odel accuracy as the regression coefﬁcientR, but in terms of the
bsolute difference between NN predictions and targets. RMSE helps
o visualise the predictive error since it is expressed in the units of
he output variable, i.e. in MPa  for CS considered in this work.
The collective performance of the NNs within a multiple run was
valuated based on the following statistical characteristics:
mean  and standard deviation  of Rtest and Rall averaged across
all NNs in the run,
the number of NNs that are statistically signiﬁcant,
the random effect threshold Rsur,max set by the highest performing
surrogate NN, in terms of Rall and Rtest .In order to select the best performing NN in a run, we considered
oth Rtrain and Rval . Commonly the validation subset is used for
odel selection [9], however under small-data conditions, Rval islligence in Medicine 75 (2017) 51–63
unreliable. On the other hand, although Rtr does not indicate the
NN performance on new samples, it gives a useful estimation of the
highest expected NN performance. It is expected that Rtr is higher
than Rval for a trained NN. Subsequently, when selecting the best
performing NN, we disregard models with Rval > Rtrainand from the
remaining models we choose the one with the highest Rval . Note
that Rtest should not be involved in the model selection as it reﬂects
the generalising performance of NN models on new data.
2.8. Alternative model: NN ensemble methods
Ensemble methods refer to powerful ML  models based on com-
bining predictions of a series of individual ML  models, such as
NNs, trained independently [43,44]. The principle behind a good
ensemble is that its constituent models are diverse and are able to
generalise over different subsets of an input space, effectively off-
setting mutual errors. The resulting ensemble is often more robust
than any of its constituent models and has superior generalisation
accuracy [43,44]. We  compared the NN ensemble performance with
that of a single NN model developed within the proposed multiple
runs framework for both the concrete and bone applications.
In an ensemble, the constituent predictor models can be diver-
siﬁed by manipulating the training subset, or by randomising their
initial parameters [44]. The former comprises boosting and bagging
techniques, which were disregarded as being impractical for the
small datasets, as they reduced already scarce training samples. We
utilised the latter ensembling strategy, where each constituent NN
was initialised with random parameters and trained with the com-
plete training set, similar to the multiple runs strategy described
in Section 2.3. Optiz & Maclin showed that this ensemble approach
was “surprisingly effective, often producing results as good as Bag-
ging” [43]. The individual predictions of the constituent NNs were
combined using a common linear approach of simple averaging
[45].
2.9. Statistical analysis
A non-parametric Wilcoxon rank sum test, also known as the
Mann–Whitney U test, for medians was utilised for comparing the
performances of any two  NN runs [46]. The null-hypothesis of no
difference between the groups was  tested at the 5% signiﬁcance
level and this is presented by p-values.
3. Investigations of the effect of data size on NN
performance: concrete CS models
In this section, we  utilise a large dataset on concrete CS,
described in Section 2.1.2, to investigate the role of dataset size
on NN performance and generalising ability. It is demonstrated
that for a larger number of samples the optimal NN coefﬁcients
can be derived without involving the proposed framework, yet the
importance of the framework increases as the data size is reduced.
3.1. Collective NN performance (per run)
First, a large-dataset NN model was  developed on a complete
dataset of 1030 samples, out of which 30% (300 samples) were
reserved for tests. The NN was  designed as in Fig. 1, with p = 8 inputs
and k = 10 neurons in hidden layer. In a multiple run of 1000, all
large-data NNs performed with statistically signiﬁcant regression
coefﬁcients (R > 0.6). As expected with large data, the collective per-
formance was highly accurate, with (Rall) = 0.95 and (Rtest) = 0.94
when averaged across the multiple run of 1000 NNs. (Fig. 3a)
Secondly, a NN was  applied to a smaller subset of the original
dataset (Fig. 3b). Out of 1030 concrete samples, 100 samples were
sampled at random and without replacement [4]. The proportions
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Fig. 3. Distributions of regression coefﬁcients Rall and Rtest across a run of neural
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Fig. 4. Distributions of regression coefﬁcients achieved by small-dataset neural net-
works for surrogates (green) and real concrete data (navy) for (a) large-dataset
model (1030 samples), (b) intermediate 100 sample model, and (c) small-datasetetworks: (a) large-dataset model (1030 samples), (b) intermediate 100 sample
odel, and (c) small-dataset model (56 samples). The inset shows the enlarged area
ighlighted in (a).
or training, validation and testing subsets, as well as the train-
ng and initialisation routines, were analogous to those used for
he large concrete dataset NN with an exception to the following
djustments:
 2000 and not 1000 NNs were evaluated per run to ensure inter-
run repeatability,
 the number of neurons in the hidden layer was reduced from 10
to 5 and the number of maximum fails for early stopping was
decreased from 10 to 6 to account for a dataset size reduction.
Finally, an extreme case with even smaller subset of the data was
onsidered (Fig. 3c). From the concrete CS dataset with 8 predictors,
6 samples were selected at random to yield the same ratio of the
umber of observations per predictor variable as in the bone CS
ataset (35 samples and 5 predictors). The small-dataset NN based
n 56 concrete samples was modelled on 41 samples and initially
ested on 15 samples.
Fig. 3 illustrates the changes to the regression coefﬁcient dis-
ributions as the size of the dataset decreased from (a) 1030 to (b)
00, and to (c) 56 samples.
In comparison to the large-dataset NNs (Fig. 3a), the distribu-
ions of the regression coefﬁcients along x-axis for smaller datasetmodel (56 samples). (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web  version of this article.)
NNs (Fig. 3b and c) were within much wider ranges. The stan-
dard deviations  also increased substantially for NN modes based
on smaller datasets compared with the initial large-dataset model
(Fig. 3a). Distributions of the regression coefﬁcients achieved by
the 2000 NN instances within the same run (Fig. 3c) demonstrate
higher intra-run variance when compared to the large-dataset NNs
(Fig. 3a). Over half of the NNs did not converge and only 762 NNs
produced statistically signiﬁcant predictions.
The mean regression coefﬁcients across the run decreased to
(Rall) = 0.719, and (Rtest) = 0.542 (Fig. 3c). When considering
only statistically signiﬁcant NNs (R > 0.6), the mean performance
of all samples was  (Rall,signif ) = 0.839 and individually for tests
(Rtest,signif ) = 0.736. Despite higher volatility, an undesirable distri-
bution spread and lower mean performance, the maximal R values
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Fig. 5. Linear regression between target and predicted compressive strength achieved by the specimen large-data (1030 samples) concrete neural network model. Values
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or the small-dataset NNs were comparable with those for the large-
ataset NNs.
.2. Surrogate data test: interpretation for various dataset sizes
As expected, NNs trained on the real concrete data consistently
utperformed surrogate NNs. Fig. 4 demonstrates how the differ-
nce in performance between the real and surrogate NNs increased
ith the dataset size.
For the large-dataset NN developed with 1030 samples (Fig. 4a),
he surrogate and real-data NN distributions did not overlap. In fact,
he surrogate NNs in this instance achieved approximately zero
ean performance, which signiﬁes that random effects would not
ave an impact on NN learning with a dataset of this size.
The 100-sample and 56-sample surrogate NNs had a non-
ero mean performance of (Rall,sur,100) = 0.219 (Fig. 4b) and
(Rall,sur,56) = 0.187 (Fig. 4c), respectively. They were also charac-
erised by a higher standard deviation of ı = 0.142 and ı = 0.145
ompared to large-dataset NNs (ı = 0.048). The non-zero mean
erformance of NNs suggests that random effects cannot be dis-
egarded with small datasets and require quantiﬁcation offered by
he proposed surrogate data test.
For 56-sample datasets (Fig. 4c), the surrogate NNs performed
ith an average regression of (Rall,sur,56)=0.187, as opposed to
(Rall,real,56) = 0.715 for real-data NNs. None of the 2000 surrogate
mall-dataset NNs achieved a statistically signiﬁcant performance
R ≥ 0.6) across all regressioin coefﬁcients, i.e. Rtrain, Rval and Rtest .d (d) the entire dataset (black). (For interpretation of the references to color in this
The surrogate threshold for the 56-sample NN was considered:
the highest performing surrogate NN achieved Rsur,max,56 = 0.791
on training dataset. This was  largely due to overtraining, as its cor-
responding performance on test samples was  poor (Rtest = 0.515).
3.3. Individual NN performance
This subsection compares performance of individual NNs: a
large-dataset NN (1030 samples) and a small-dataset NN (56 sam-
ples) developed using the proposed framework. As shown in Fig. 3a,
all large-data NNs performed with high accuracy and small vari-
ance, thus one of them could be selected as a working model
without the need for multiple runs. The performance of one of 1000
large-data NN from the run in Fig. 3a is demonstrated in Fig. 5.
This NN achieved (Rall) = 0.944 and generalised with (Rtest) = 0.94
on 300 independent test samples (Fig. 5d). This large-dataset model
provides an indication of NN performance achieved with abundant
training samples.
For small datasets, we are now concerned with NNs that perform
above the surrogate data threshold of Rsur,max,56 = 0.791 established
in Section 3.2. Among the 2000 small-dataset (56-sample) NNs,
the best-performing NN was selected using the performance cri-
teria in Section 2.7. This model achieved regression coefﬁcients
of (Rall) = 0.92 on the entire dataset, and separately: (Rtrain) = 0.96,
(Rval) = 0.92 and (Rtest) = 0.90 on 15-sample test (Fig. 6a–d). In
comparison, the large-dataset NN developed with 1030 samples
performed only 2.12% higher. The Rvalues were well above the
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eported individually for (a) training (blue), (b) validation (green) and (c) testing (re
nterpretation of the references to color in this ﬁgure legend, the reader is referred 
urrogate threshold, indicating that high performance of the small-
ata NN was not due to luck. This result was conﬁrmed when the
mall-data NN was subjected to the generalisation assessment on
ew test samples.
.4. Generalising performance of the small-dataset NN
In order to assess generalisation, 300 new test samples were
andomly selected from the available dataset of 1030–56 = 974
amples not previously seen by the NN. Modelled with only 41 sam-
les, the NN was able to predict CS on 300 new test samples with
test,300 = 0.865 (Fig. 6e); the corresponding RMSE was 9.5 MPa. This
onstitutes a 7.5% decrease in generalising performance compared
o the specimen large-dataset NN tested with the same number of
ndependent samples (Fig. 5c).
In other words, using the proposed framework we  were able
o develop an 86.5% accurate NN model with an 18 times smaller
ataset than the original one, which demonstrates superiority of
he suggested methodology and its applicability to the problems
haracterised by restricted dataset sizes.
.5. Comparison of the small-dataset NN with the ensemble
odel for the concrete CS data
Firstly, an NN ensemble was designed by combining the outputs
f 1000 NNs trained with the complete dataset of concrete samples
analogous to the large-dataset NNs described in Section 3.1 and
resented in Fig. 3a). As anticipated, this NN ensemble was able
o achieve a superior generalisation accuracy of Rtest = 0.96 when
ested on 300 independent samples.y the small-dataset (56 samples) optimised concrete neural network. Values are
) the entire dataset (black), and (e) for 300 independent test samples (purple). (For
 web  version of this article.)
The second NN ensemble was  designed by combining the 2000
56-sample NNs (analogous to the small-dataset NNs in Section 3.1
and Fig. 3c). This ensemble achieved Rtest = 0.81 on 15 independent
test samples. In comparison, our small-dataset concrete NN model
developed with the multiple runs technique achieved Rtest = 0.903
on the same test samples. Subsequently the generalising ability of
this ensemble was  assessed on 300 additional concrete samples.
The ensemble was able to retain its generalising ability with the
accuracy of Rtest,300 = 0.81, proving its robustness, irrespective of
the test sample size.
Despite such striking consistency, the accuracy of the ensemble
model was decreased by over 8% when compared with the general-
ising performance of the single NN model, developed using method
of multiple runs (Rtest,300 = 0.865, Section 3.3). These results demon-
strate that a NN ensemble can achieve a remarkable performance
on predictive tasks with sufﬁcient data, but is unable to perform as
well as the multiple runs model on small datasets.
4. Results: bone CS model
4.1. NN design conﬁguration
The NN design described in Section 2.2 for bone CS data com-
prised 5 input parameters. The heterogeneous 1 × 5 input vector,
x¯, was  stacked in the following order: x1 = morphology (SMI),
x2 = level of interconnectivity (tb.th), x3 = porosity (BV/TV), x4 = age
and x5 = gender. Following a standard parameter estimation rou-
tine, but with the help of multiple runs, the NN design was
conﬁgured to 4 neurons in the hidden layer (Appendix B). The num-
ber of permissible consecutive validation iterations during which
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he NN performance fails to improve and which directly inﬂuences
uration of NN training, was set to 9 (Appendix B).
.2. Surrogate data test
Performances of the NNs trained with real and surrogate data
ere compared by assessing 10 runs of 2000 NNs, i.e. a total
f 20,000 NNs. The real dataset NNs consistently outperformed
he surrogate NNs with, on average, a 35% performance increase
Fig. 7a).
Wilcoxon rank sum tests for median Rall and Rtest across 20,000
Ns revealed signiﬁcant statistical difference (p = 0) between the
roups, with median Rall,sur = 0.38 for surrogates versus median
all,real = 0.78 for the real dataset (Fig. 7b). Similar differences in the
istributions of Rtest,real and Rtest,sur were observed for tests sam-
les (Fig. 7c–d). The surrogate threshold was Rsur,max = 0.87 which
ndicated the lower performance threshold for the real dataset NN.
verall, the surrogate test signiﬁed that the accurate results yielded
y the bone NN model are not due to random effects.
.3. Optimal bone CS model
Among the run of 2000 NNs of optimal design, the best-
erforming NN was capable of predicting trabecular tissue CS with
MSE = 0.85 MPa  on the test samples. The linear regression coefﬁ-
ients between targets and predictions achieved by the NN were:
ndividually for Rtr = 0.999, Rval = 0.991, Rtest = 0.983 and Rall= 0.993
Fig. 8a–d). This indicates a very high accuracy of predictions
espite the limited dataset of 35 samples. The ﬁnal values ofogates (light blue) and real bone data (navy) and (b) Wilcoxon rank sum test for
e reported in (c) and (d). (For interpretation of the references to color in this ﬁgure
weights and biases of this fully-trained network are provided in
Appendix C.
4.4. Comparison with ensemble NN
The NN ensemble achieved Rtest = 0.882, which is 11% lower
than the accuracy of the proposed multiple run NN model
(Rtest = 0.983) and only marginally higher than the surrogate
thresholdRsur,max = 0.87 established in Section 4.2 for the bone
dataset. This result further conﬁrms that the NN ensembles, when
tasked with small-dataset applications, were unable to realise their
full predictive potential and were inferior to NNs designed within
a multiple runs framework.
5. Discussion
5.1. Signiﬁcance of the proposed methodology
A framework for the application of regression NNs to medical
datasets has been developed in order to mitigate the small dataset
problem. NNs trained with small datasets exhibit sporadic ﬂuctua-
tions in the performance due to degrees of randomness inherent in
the NN initialisation and training routines. This raises the problem
of consistent comparisons between various NN models. Another
problem is the evaluation of NN performance in the presence of ran-
dom effects when the test data are scarce. The limitations of small
datasets have been overcome in this work by using a novel frame-
work comprising: (1) a multiple runs strategy for monitoring the
performance measures collectively across a large set of NNs, and (2)
surrogate data analysis for model validation. The proposed surro-
gate data approach provided a mechanism for NN model validation
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here no additional test samples were available. A large-scale
tudy involving 20,000 NNs conﬁrmed that NNs trained on real
one data signiﬁcantly outperform the NNs trained on surrogate
ata.
The framework has been evaluated via a comparative study that
redicted concrete CS using both large (1030 samples) and small
56 samples) datasets. Using the proposed framework it was possi-
le to develop a small-dataset NN with performance Rall = 0.923
omparable with that of a large-dataset NN (Rall = 0.944). This
emonstrates that a drastic 18 times reduction in the required
ataset size corresponds to only a small decrease in accuracy of
.12% – a compromise to be considered in single-center studies
here datasets are often limited.
When applied to 35 osteoarthritic specimens, our methodology
ielded a reliable predictive NN tool for non-destructive estima-
ion of bone compressive strength. The optimised NN achieved a
igh generalising accuracy of 98.3%. Additionally, by quantifying
andom effects speciﬁc to the dataset, the surrogate data approach
llowed us to deﬁne a performance threshold of Rsur,max = 0.87 for
uccessful NNs. The successful application of the proposed method-
logy conﬁrms that the size of datasets does not necessarily limit
he utility of NNs in the medical domain.
.2. Practical signiﬁcance of the bone CS modelIn cellular solids, CS is an exponential function of the apparent
ensity, BV/TV, raised to the power of 3/25 [15,25,47]. Although
uch an exact relationship has not been established speciﬁcally fora) achieved by the bone neural network. Values were reported individually for a)
). (For interpretation of the references to color in this ﬁgure legend, the reader is
osteoarthritic trabecular tissue, this power model, with a bivariate
regression coefﬁcient Rpowermodel = 0.906 is the best existing ﬁt to the
data [17]. The generalising NN performance Rtest = 0.983 achieved
in our study exceeded Rpowermodel by 8.5%. The proposed NN model
yields substantially more accurate predictions by considering vari-
able interrelations within multi-dimensional medical datasets and
successfully capturing the complex physiological phenomena in
patients suffering from severe OA.
The high accuracy of the proposed CS model enables predic-
tion of bone fracture risk based on the structural and physiological
parameters that can be derived without invasive tests on the
patient. Hence, by predicting how CS correlates with the bone vol-
ume  fraction, trabecular thickness and structure model index for
patients of various age and gender groups, the NN model can pro-
vide a decision support tool for hard tissue engineers and clinicians
alike [26]. To our best knowledge, the NN presented in this work
is the only existing patient-speciﬁc model for prediction of CS in
trabecular bone affected by OA.
The potential practical applications include: the estimation of
bone fracture risk in osteoarthritic patients from CT-scans and basic
physiological data, load modelling of synthetic bioscaffolds that
mimic  natural trabecular bone damaged by OA, and the tailoring of
bioscaffold designs for an individual patient to match the damaged
trabecular tissue at the site of implantation.
The predictive NN model can be adapted to larger datasets and
to other degenerative bone disorders, such as osteoporosis and
metastatic cancer, with marginal increase in design effort and cost
[8,9]. Such scalability is inherent in the underlying ML  algorithms,
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Table A2
Surrogates.
Sample no. SMI  tb.th BV/TV Age
(years)
Gender
(F = 1)
CS
(MPa)
1 1.00 260 32.3 66.8 1 17.43
2  0.58 217 38.0 54.0 0 16.21
3  0.73 260 40.5 82.7 1 6.95
4  0.13 209 19.3 57.4 0 19.89
5  0.53 185 17.6 80.4 1 28.51
6  1.72 314 30.5 55.9 0 13.48
7  0.67 269 16.0 60.9 1 26.99
8  0.63 336 26.8 49.6 1 13.33
9  0.12 287 26.9 68.9 0 23.77
10  0.58 271 35.0 54.2 0 15.24
11  0.80 306 26.0 46.6 1 14.52
12  0.90 320 24.1 71.6 1 10.76
13  0.42 376 29.9 60.1 0 8.40
14  0.37 155 31.5 69.6 1 12.63
15  1.93 317 26.7 61.3 0 20.02
16  −0.49 275 23.1 68.5 1 21.19
17  1.38 378 18.0 44.5 1 19.40
18  1.47 264 28.1 79.5 0 2.93
19  1.14 258 21.1 74.4 1 22.59
20  −0.23 304 13.5 72.4 1 24.92
21  0.18 224 31.9 74.9 1 20.93
22  0.32 261 20.6 61.2 1 5.17
23  0.90 326 25.1 68.2 1 13.90
24  −0.11 270 30.3 66.9 0 19.60
25  0.98 312 23.3 65.6 0 20.09
26  −0.20 293 31.4 57.8 0 10.90
27  0.86 272 24.1 56.8 1 11.85
28  0.59 227 30.2 63.3 1 19.02
29  1.10 283 30.6 56.1 1 15.62
30  0.97 194 25.1 74.6 0 18.13
31  1.44 277 11.7 85.3 1 11.17
32  1.39 282 22.7 45.3 0 9.80
33  0.32 292 24.7 65.8 0 22.25
34  0.94 323 21.3 49.6 0 20.85
35  0.04 367 19.4 74.5 1 25.36
Surrogate data were synthesised as a random normal distribution with the mean
and standard deviation of the real bone data within the same range.0 T. Shaikhina, N.A. Khovanova / Artiﬁci
hich enable NNs to learn and improve their performance with
ew data [10,14,48,49].
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ppendices
ppendix A. Trabecular bone data: real vs surrogate
amples
See Tables A1 and A2
able A1
eal bone data.
Sample no. SMI  tb.th BV/TV Age
(years)
Gender
(F = 1)
CS
(MPa)
1 0.06 243 32.5 41.8 1 20.9
2  1.42 224 21.5 52.0 1 6.91
3  0.48 239 26.6 57.0 1 18.2
4  −0.82 212 43.5 63.9 1 9.46
5  1.22 419 17.9 64.0 1 23.1
6  0.64 223 27.6 67.1 1 19.4
7  2.10 197 9.82 68.1 1 2.76
8  0.38 367 26.9 71.5 1 18.9
9  0.80 218 15.4 74.9 1 6.49
10  0.54 314 25.0 76.0 1 17.8
11  0.30 326 32.4 87.0 1 24.2
12  −0.17 287 30.4 41.7 0 21.5
13  −0.31 284 37.0 47.9 0 16.4
14  0.04 265 38.7 49.8 0 11.1
15  0.82 241 22.7 49.8 0 26.5
16  −0.23 303 37.6 65.8 0 28.8
17  1.77 219 25.3 68.0 0 4.91
18  1.33 261 17.4 72.9 0 9.81
19  0.04 307 29.7 73.9 0 23.7
20  0.36 271 31.6 81.8 0 24.4
21  0.31 252 33.8 60.9 1 20.5
22  0.70 283 22.5 62.9 1 12.2
23  1.59 247 13.7 72.6 1 1.93
24  0.45 257 27.4 45.7 0 19.6
25  0.44 266 27.5 62.9 0 18.5
26  0.15 270 32.1 77.8 0 22.2
27  1.08 193 19.4 87.0 0 9.12
28  1.93 154 9.68 49.0 1 8.22
29  0.92 263 25.3 66.0 1 15.4
30  −0.43 299 39.7 69.9 1 23.2
31  1.04 239 21.0 73.9 1 8.15
32  −0.05 288 35.6 46.8 0 24.3
33  0.39 246 26.6 64.9 0 19.3
34  0.71 178 12.2 68.0 0 14.0
35  0.70 234 21.8 84.9 0 13.3
one data were extracted from the original study from [17] using a Plot Digitiser
ool.
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ppendix B. NN design parameter estimation for bone CS
ata
ffects of the number of neurons in hidden layer
Limited availability of the training samples necessitates careful
election of the size of the hidden layer in order to achieve well-
eneralising NNs. The effect of increasing number of neurons in
he hidden layer from 1 to 13 was investigated in the series of
xperiments that involved 10 runs of 2000 NNs for each neuron,
.e. 260,000 NNs in total were analysed for enhanced repeatability.
Reported in Fig. A1 is the number of statistically signiﬁcant NNs,
.e. NNs that exhibited performance of Rall ≥ 0.6 across the entire
ataset, as well as individually for the training, validation and test
atasets. Despite the inter-run volatility in the results, on average
he highest performing NNs had 2, 3, 4, and 5 neurons in hidden
ayer with 890, 878, 873 and 851 statistically signiﬁcant NNs per
un, respectively.
For statistically signiﬁcant NNs the distributions of Rall and Rval
ere compared for various neuron conﬁgurations. The highest Rval
as achieved in NN designs with 3 and 4 neurons. The Wilkinson
Fig. A1. Number of statistically signiﬁcant NNs per run f
Fig. A2. Distributions of the effective number of parameters in regularisedlligence in Medicine 75 (2017) 51–63 61
rank sum test was  used to assess the inter-run volatility for the two
candidate designs. Based on comparison of the 50 pairwise p-values
at 5% conﬁdence level, NNs with 4 neurons were established to be
more stable than those with 3 neurons. Following careful evalua-
tion of the largest number of statistically signiﬁcant NNs produced,
the highest Rall and Rval performance, and adequate inter-run sta-
bility, NN with 4 neurons in a hidden layer was chosen as the ﬁnal
NN design for the next stage in parameter estimation.
Another way to identify optimal NN size is by integrating a
parameter regularisation into a training process. A weight decay
procedure penalises large weights forcing the NN parameters to
shrink. Larger networks have more parameters to start with, but
regularisation prevents some of this ‘excessive capacity’ from being
trained unnecessarily. The effective number of parameters in a NN
trained with regularisation can serve as an indication of how well
the NN utilises its capacity. We  investigated the number of effective
parameters for NNs of varying hidden layer size (from 1 to 20 neu-
rons) trained by Bayesian regularisation backpropagation (Fig. A2).
The number of effective parameters rose in NN conﬁgurations with
1–4 neurons and fell in conﬁgurations with 5 neurons and above,
indicating that the NN with 4 neurons was most effective. This
or various number of neurons in the hidden layer.
 neural networks for various number of neurons in the hidden layer.
6 al Intelligence in Medicine 75 (2017) 51–63
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Table A3
Weights and biases.
IW 0.887 2.382 −0.888 −3.584
1.301 −1.586 0.904 −3.841
−3.268 0.632 −1.342 −0.144
−1.216 −2.153 −1.380 −3.000
−0.620 1.592 −0.379 −1.169
lw′ −0.698
−0.151
2.349
−1.5012 T. Shaikhina, N.A. Khovanova / Artiﬁci
as further conﬁrmed by considering validation performance Rval
cross 20 runs, which was highest for the NNs with 4 neurons.
ffects of the training duration
Training duration stipulates the balance between the NN train-
ng performance and generalisation. Although extended training
an lead to exceptional performance on the training dataset, it often
esults in poor generalisation on the test data that the NNs had
ot seen before. Early stopping helps to avoid NN over-ﬁtting upon
eaching the maximum number of validation checks. The number,
, of consecutive validation iterations during which the NN perfor-
ance fails to decrease plays key role in controlling the quality of
N training. It also affects computational efﬁciency of the training
lgorithm, which deteriorates with the increasing n.
When investigated on 20 runs of 2000 NNs, corresponding to n
rom 1 to 10 in the increments of 1 and 10–100 in the increments
f 10, the effect ofn  on the NN performance was marginal. No sta-
istical difference was established between the distributions of R
neither Rval nor Rall) for various n in any possible pair of Wilkinson
ank sum comparisons at 5% signiﬁcance level. Thus, any conﬁgu-
ation that yielded the highest values of Rall and Rvalwas  a suitable
andidate for the ﬁnal NN. Based on the above considerations, the
 value of 9 allowed for maximum performance across all samples
hile maintaining adequate simulation efﬁciency.
ppendix C. Values of weights and biases of the ﬁnal NN
odel for trabecular bone data
The small-dataset bone CS NN was trained using the Levenberg
arquardt backpropagation algorithm [37]. During each iteration
epoch), the performance of the NN on training, validation and test
amples was monitored in terms of its cost function expressed by
SE.
Fig. A3 shows how the NN error on the training set was  mono-
onically decreasing with each epoch. The errors on the validation
nd test samples were sporadic until the 14th epoch. At the 31st
poch the validation error failed to decrease for 9 consecutive itera-
ions and the early stopping criterion was reached. The weights and
iases were then reverted by 9 epochs to the state at which the val-
dation error was least, i.e. the ﬁnal state of the trained NN weights
ig. A3. Neural network cost function dynamics during the 30 epoch of training
blue), validation (green) and testing (red). Upon reaching the 9th validation check
t  22nd epoch (green circle), the neural network training process was  completed.
[
[
[
[
[
[
[
[
[
[
[
[
[b(1) 0.268 −0.006 −1.224 −4.972
b(2) 0.623
and biases corresponded to the 22nd epoch. Notably, this is not
the state that minimises cost function for the test samples, as these
independent test samples were not involved in the model train-
ing; their corresponding cost function is provided for illustrative
purposes.
Table A3 shows the ﬁnal weight and bias parameters for the
trained bone NN: the input weights matrix IW ,  the layer weights
column vector lw′, and the corresponding biases b(1) and b(2).
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